Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models.

Autor: Tucker ER; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Jiménez I; SiRIC RTOP (Recherche Translationelle en Oncologie Pédiatrique), Translational Research Department, Institut Curie Research Center, PSL Research University, Institut Curie, Paris, France.; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France., Chen L; Wolfson Childhood Cancer Research Centre, Translational & Clinical Research Institute, Newcastle Centre for Cancer, Newcastle University, Newcastle upon Tyne, United Kingdom., Bellini A; SiRIC RTOP (Recherche Translationelle en Oncologie Pédiatrique), Translational Research Department, Institut Curie Research Center, PSL Research University, Institut Curie, Paris, France.; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France., Gorrini C; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Calton E; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Gao Q; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Che H; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Poon E; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Jamin Y; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Martins Da Costa B; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Barker K; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Shrestha S; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Hutchinson JC; Department of Histopathology, Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom., Dhariwal S; Wolfson Childhood Cancer Research Centre, Translational & Clinical Research Institute, Newcastle Centre for Cancer, Newcastle University, Newcastle upon Tyne, United Kingdom., Goodman A; Newcastle Genetics Laboratory, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom., Del Nery E; Department of Translational Research, The Biophenics High-Content Screening Laboratory, PSL Research University, PICT-IBiSa, Institut Curie Research Center, Paris, France., Gestraud P; Bioinformatics platform, INSERM U900, PSL Research University, Institut Curie Research Center, Paris, France., Bhalshankar J; SiRIC RTOP (Recherche Translationelle en Oncologie Pédiatrique), Translational Research Department, Institut Curie Research Center, PSL Research University, Institut Curie, Paris, France.; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France., Iddir Y; SiRIC RTOP (Recherche Translationelle en Oncologie Pédiatrique), Translational Research Department, Institut Curie Research Center, PSL Research University, Institut Curie, Paris, France.; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France., Saberi-Ansari E; SiRIC RTOP (Recherche Translationelle en Oncologie Pédiatrique), Translational Research Department, Institut Curie Research Center, PSL Research University, Institut Curie, Paris, France.; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France., Saint-Charles A; SiRIC RTOP (Recherche Translationelle en Oncologie Pédiatrique), Translational Research Department, Institut Curie Research Center, PSL Research University, Institut Curie, Paris, France.; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France., Geoerger B; Gustave Roussy Cancer Center, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, Villejuif, France., Marques Da Costa ME; Gustave Roussy Cancer Center, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, Villejuif, France., Pierre-Eugène C; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France., Janoueix-Lerosey I; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France., Decaudin D; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University, Paris, France.; Department of Medical Oncology, Institut Curie, Paris, France., Nemati F; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University, Paris, France., Carcaboso AM; Hospital Sant Joan de Déu, Barcelona, Spain., Surdez D; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France.; Balgrist University Hospital, Faculty of Medicine, University of Zurich (UZH), Zurich, Switzerland., Delattre O; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France., George SL; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Chesler L; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Tweddle DA; Wolfson Childhood Cancer Research Centre, Translational & Clinical Research Institute, Newcastle Centre for Cancer, Newcastle University, Newcastle upon Tyne, United Kingdom., Schleiermacher G; SiRIC RTOP (Recherche Translationelle en Oncologie Pédiatrique), Translational Research Department, Institut Curie Research Center, PSL Research University, Institut Curie, Paris, France.; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Apr 03; Vol. 29 (7), pp. 1317-1331.